ALKS FY 2017 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$903M+21.1% YoY

Gross Profit

$749M82.9% margin

Operating Income

-$148M-16.4% margin

Net Income

-$158M-17.5% margin

EPS (Diluted)

$-1.03

Cash Flow

Operating Cash Flow

$19M

Free Cash Flow

-$32M

Stock-Based Comp.

$84M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$594M

Stockholders' Equity

$1.2B

Cash & Equivalents

$191M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$903M	$746M	+21.1%
Gross Profit	$749M	$614M	+22.0%
Operating Income	-$148M	-$209M	+29.1%
Net Income	-$158M	-$208M	+24.2%